[ad_1] [아시아경제 박혜정 기자] The National Cancer Center announced on June 16 that it had entered into an exclusive licensing agreement for the development of an immunochemotherapy technology using genetically engineered T …
Read More »National Cancer Center – Tikaros, Convention on the Transfer of Technology for the Development of Immune Cancer Drugs
